Company / Profit Margin
Sunshine Biopharma Inc. Profit Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-14.7%
FY2025
5-year range
-5444.4% / -14.7%
FY2021-FY2025
Trend
+21.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Profit Margin has increased for 3 consecutive years, from -5444.4% in FY2022 to -14.7% in FY2025.
Based on SEC 10-K filings.
-14.7% in FY2025 with a 5-year CAGR of +7846.1%.
Improved from -615.4% to -14.7% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- +5429.7pp
- 5-Year Change
- +7846.1pp
- 10-Year Change
- -
Key checks
Key Insights
- Sunshine Biopharma Inc.'s profit margin has grown for 3 consecutive years.
- In FY2025, profit margin increased 21.3% year-over-year.
- Lowest profit margin in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -14.7% | +21.3% |
| FY2024 | -18.7% | +97.0% |
| FY2023 | -615.4% | +88.7% |
| FY2022 | -5444.4% | -39.6% |
| FY2021 | -3898.7% | +50.4% |
| FY2020 | -7860.9% | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | -96774.5% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026